Skip to main content
OpenTrials
Completed

NCT Number: NCT07551453

The Return-to-Work Experience of Cancer Patients: A Descriptive Phenomenological Study

This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience. The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centro di riferimento Oncologico di Aviano

Aviano, Pordenone, 33081, Italy

About this study

This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience. The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 18 years of age or older.
  • Diagnosis: Primary diagnosis of neoplasm.
  • Treatment: Currently undergoing at least one anticancer treatment (pharmacological/systemic therapy, surgery, or radiotherapy).
  • Setting: Patients managed in a Day Hospital or outpatient setting.
  • Employment Status: Engaged in paid and continuous professional activity at the time of diagnosis.
  • Language: Ability to understand and speak the Italian language fluently.
  • Informed Consent: Ability to provide written informed consent for study participation and data processing (privacy) in accordance with local regulations.

Exclusion criteria

  • Pre-existing Unemployment: Individuals who were not employed prior to the onset of the disease.
  • Psychiatric or Cognitive Impairment: Current diagnosis of psychiatric disorders or cognitive dysfunction that may interfere with the ability to participate in the interview.
  • Terminal Prognosis: Patients with a diagnosis of terminal illness or end-of-life status.
  • Lack of Voluntary Consent: Individuals who voluntarily choose not to participate in the project or withdraw consent.

Treatment and study plan

Primary outcomes

  1. Perception of Work Experience and Unmet Health Needs

    Time frame: up to 1 year

    A qualitative assessment of how cancer patients perceive their professional life during treatment will be carried out using Colaizzi framework (1978). The study uses semi-structured interviews to identify "unexpressed health needs"-specific physical, psychological, or organizational requirements related to working while undergoing therapy that are not currently addressed by standard care.

Secondary outcomes

  1. Identification of Potential Nursing Interventions for Work-Related Support

    Time frame: up to 1 year

    Analysis of patient interviews using a qualitative approach to categorize and define specific nursing actions that can address the work-related health needs identified in the primary objective.

Sponsors and collaborators

Lead sponsor

Centro di Riferimento Oncologico - Aviano

Other

Registry information

Acronym: REWORK

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 24, 2026
Registry last updated
Apr 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.